0 results for 'undefined'
Bristol-Myers CEO and GC Resign in Midst of Federal Probe
Bristol-Myers Squibb's CEO Peter Dolan and General Counsel Richard Willard resigned Tuesday, spurred by the recommendations of a federal monitor, after the company came perilously close to violating a deferred-prosecution agreement entered last year in the face of conspiracy and securities-fraud charges. Under such an accord, the monitor's recommendation generally carries the force of an order, say securities lawyers.Clifford Chance Advises Temasek on ICBC Deal
Clifford Chance has acted for Singapore's sovereign wealth fund, Temasek Holdings Pte. Ltd., in its $2.3 billion purchase of Industrial and Commercial Bank of China Ltd. shares from The Goldman Sachs Group Inc.View more book results for the query "*"
Pepper IP Lawyer Joins Defense Team in Mockingbird Suit
Three defendants accused of duping Harper Lee out of the copyright to To Kill a Mockingbird bolstered their legal team this week when a federal judge allowed Pepper Hamilton IP cochair Vincent Carissimi to represent them.Opinion: Tale of the Tape III: Films of A Lesser Law
I am banking on public appetite for the familiar. The summer of 2013 has been a historically bad season for movie studios, as one blockbuster after another (Pacific Rim, anyone?) has bombed at the box office. One exception, however, is sequels — three of the top-ten grossing films of 2013 have a numeral at the end of their title.In re: NYSE Specialists Securities Litigation
Circuit Revives Investors' Market Integrity Misrepresentation Claim Against Stock ExchangeBeyond the Shelves: Law Libraries Offer More Than Books
Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250